2007Chinese Journal of Clinical PharmacyRequires access

Bioequivalence of ambroxol hydrochloride orally disintegrating tablets in healthy volunteers

Gao Juan

Open publisher page 0 citations

Abstract

AIM To study the bioequivalence between test drug(ambroxol hydrochloride orally disintegrating tablets) and its reference drug(ambroxol).METHODS A single dose of 90 mg test drug and reference drug were given to 19 healthy male volunteers.HPLC method was developed to determine the concentrations of ambroxol in human plasma.The data were analyzed by the BAPP 2.0 program.RESULTS The main pharmacokinetic parameters of test drug and its reference drug were as follows:ρmax were(168.34±41.16)μg·L-1 and(168.60±46.40)μg·L-1;tmax were (1.6±0.5)h and(2.2±0.7)h.t12 were (6.21±1.75)h and(6.31±1.99)h.AUC0→24 were(1 171.65±372.37)μg·h·L-1 and(1 115.81±342.11)μg·h·L-1,respectively.The relative bioavailability of test drug was(106.2±19.6)%.CONCLUSION The results of statistical analysis for the ρmax and AUC0→24 show that the two preparations are bioequivalent.There are singnificant differences in tmax between two preparations and the ambroxol hydrochloride orally disintegrating tablets are absorbed faster.

About this research paper

What this paper is about

AIM To study the bioequivalence between test drug(ambroxol hydrochloride orally disintegrating tablets) and its reference drug(ambroxol).METHODS A single dose of 90 mg test drug and reference drug were given to 19 healthy male volunteers.HPLC method was developed to determine the concentrations of ambroxol in human plasma.The data were analyzed by the BAPP 2.0 program.RESULTS The main pharmacokinetic parameters of test drug and its reference drug were as follows:ρmax were(168.34±41.16)μg·L-1 and(168.60±46.40)μg·L-1;tmax were (1.6±0.5)h and(2.2±0.7)h.t12 were (6.21±1.75)h and(6.31±1.99)h.AUC0→24 were(1 171.65±372.37)μg·h·L-1 and(1 115.81±342.11)μg·h·L-1,respectively.The relative bioavailability of test drug was(106.2±19.6)%.CONCLUSION The results of statistical analysis for the ρmax and AUC0→24 show that the two preparations are bioequivalent.There are singnificant differences in tmax between two preparations and the ambroxol hydrochloride orally disintegrating tablets are absorbed faster.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM To study the bioequivalence between test drug(ambroxol hydrochloride orally disintegrating tablets) and its reference drug(ambroxol).METHODS A single dose of 90 mg test drug and reference drug were given to 19 healthy male volunteers.HPLC method was developed to determine the concentrations of ambroxol in human plasma.The data were analyzed by the BAPP 2.0 program.RESULTS The main pharmacokinetic parameters of test drug and its reference drug were as follows:ρmax were(168.34±41.16)μg·L-1 and(168.60±46.40)μg·L-1;tmax were (1.6±0.5)h and(2.2±0.7)h.t12 were (6.21±1.75)h and(6.31±1.99)h.AUC0→24 were(1 171.65±372.37)μg·h·L-1 and(1 115.81±342.11)μg·h·L-1,respectively.The relative bioavailability of test drug was(106.2±19.6)%.CONCLUSION The results of statistical analysis for the ρmax and AUC0→24 show that the two preparations are bioequivalent.There are singnificant differences in tmax between two preparations and the ambroxol hydrochloride orally disintegrating tablets are absorbed faster.

Key concepts: Bioequivalence, Ambroxol, Bioavailability, Pharmacology, Pharmacokinetics, Drug, Hydrochloride, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of ambroxol hydrochloride orally disintegrating tablets in healthy volunteers — Research Paper | ScholarLens